Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors.
Chen CL, Pan QZ, Weng DS, Xie CM, Zhao JJ, Chen MS, Peng RQ, Li DD, Wang Y, Tang Y, Wang QJ, Zhang ZL, Zhang XF, Jiang LJ, Zhou ZQ, Zhu Q, He J, Liu Y, Zhou FJ, Xia JC.
Chen CL, et al. Among authors: zhu q.
Oncoimmunology. 2018 Jan 10;7(4):e1417721. doi: 10.1080/2162402X.2017.1417721. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29632736
Free PMC article.